Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Emergent Biosolutions Inc’s stock clocked out at $11.02, down -1.52% from its previous closing price of $11.19. In other words, the price has decreased by -$1.52 from its previous closing price. On the day, 0.73 million shares were traded. EBS stock price reached its highest trading level at $11.2899 during the session, while it also had its lowest trading level at $10.58.
Ratios:
To gain a deeper understanding of EBS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeGolyer Donald W sold 25,000 shares for $10.91 per share. The transaction valued at 272,750 led to the insider holds 111,100 shares of the business.
White Marvin L sold 14,287 shares of EBS for $171,015 on Nov 11 ’24. The Director now owns 54,092 shares after completing the transaction at $11.97 per share. On Nov 12 ’24, another insider, DeGolyer Donald W, who serves as the Director of the company, bought 25,000 shares for $11.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 597109888 and an Enterprise Value of 1123209728. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.53 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 0.998 whereas that against EBITDA is -234.002.
Stock Price History:
The Beta on a monthly basis for EBS is 1.61, which has changed by 5.5988026 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 16.95%, while the 200-Day Moving Average is calculated to be 37.94%.
Shares Statistics:
It appears that EBS traded 1.24M shares on average per day over the past three months and 1054140 shares per day over the past ten days. A total of 54.10M shares are outstanding, with a floating share count of 52.75M. Insiders hold about 2.64% of the company’s shares, while institutions hold 58.37% stake in the company. Shares short for EBS as of 1736899200 were 7040698 with a Short Ratio of 5.68, compared to 1734048000 on 6936897. Therefore, it implies a Short% of Shares Outstanding of 7040698 and a Short% of Float of 15.790000000000001.
